Bulgaria - Sofia: Pharmaceutical products

Release

ID
ocds-pyfy63:2020-211846:2020-211846
Date
2020-05-07
Language
BG
Tags
tender

Release in JSON

Process

ID (OCID)
ocds-pyfy63:2020-211846
Releases
2020-05-07 (ocds-pyfy63:2020-211846:2020-211846)
2020-08-28 (ocds-pyfy63:2020-211846:2020-403474)

Releases in JSON

Tender

Title
Bulgaria - Sofia: Pharmaceutical products
Award criteria
priceOnly
Award criteria details
Lowest price

Award criteria for item 1:
- Price

Award criteria for item 2:
- Price

Award criteria for item 3:
- Price

Award criteria for item 4:
- Price

Award criteria for item 5:
- Price

Award criteria for item 6:
- Price

Award criteria for item 7:
- Price

Award criteria for item 8:
- Price

Award criteria for item 9:
- Price

Award criteria for item 10:
- Price

Award criteria for item 11:
- Price

Award criteria for item 12:
- Price

Award criteria for item 13:
- Price

Award criteria for item 14:
- Price

Award criteria for item 15:
- Price

Award criteria for item 16:
- Price

Award criteria for item 17:
- Price

Award criteria for item 18:
- Price

Award criteria for item 19:
- Price

Award criteria for item 20:
- Price

Award criteria for item 21:
- Price

Award criteria for item 22:
- Price

Award criteria for item 23:
- Price

Award criteria for item 24:
- Price

Award criteria for item 25:
- Price

Award criteria for item 26:
- Price

Award criteria for item 27:
- Price

Award criteria for item 28:
- Price

Award criteria for item 29:
- Price

Award criteria for item 30:
- Price

Award criteria for item 31:
- Price

Award criteria for item 32:
- Price

Award criteria for item 33:
- Price

Award criteria for item 34:
- Price

Award criteria for item 35:
- Price

Award criteria for item 36:
- Price

Award criteria for item 37:
- Price

Award criteria for item 38:
- Price

Award criteria for item 39:
- Price

Award criteria for item 40:
- Price

Award criteria for item 41:
- Price

Award criteria for item 42:
- Price

Award criteria for item 43:
- Price

Award criteria for item 44:
- Price

Award criteria for item 45:
- Price

Award criteria for item 46:
- Price

Award criteria for item 47:
- Price

Award criteria for item 48:
- Price

Award criteria for item 49:
- Price

Award criteria for item 50:
- Price

Award criteria for item 51:
- Price

Award criteria for item 52:
- Price

Award criteria for item 53:
- Price

Award criteria for item 54:
- Price

Award criteria for item 55:
- Price

Award criteria for item 56:
- Price

Award criteria for item 57:
- Price

Award criteria for item 58:
- Price

Award criteria for item 59:
- Price

Award criteria for item 60:
- Price

Award criteria for item 61:
- Price

Award criteria for item 62:
- Price

Award criteria for item 63:
- Price

Award criteria for item 64:
- Price

Award criteria for item 65:
- Price

Award criteria for item 66:
- Price

Award criteria for item 67:
- Price

Award criteria for item 68:
- Price

Award criteria for item 69:
- Price

Award criteria for item 70:
- Price

Award criteria for item 71:
- Price

Award criteria for item 72:
- Price

Award criteria for item 73:
- Price

Award criteria for item 74:
- Price

Award criteria for item 75:
- Price

Award criteria for item 76:
- Price

Award criteria for item 77:
- Price

Award criteria for item 78:
- Price

Award criteria for item 79:
- Price

Award criteria for item 80:
- Price

Award criteria for item 81:
- Price

Award criteria for item 82:
- Price

Award criteria for item 83:
- Price

Award criteria for item 84:
- Price

Award criteria for item 85:
- Price

Award criteria for item 86:
- Price

Award criteria for item 87:
- Price

Award criteria for item 88:
- Price

Award criteria for item 89:
- Price

Award criteria for item 90:
- Price

Award criteria for item 91:
- Price

Award criteria for item 92:
- Price
Award period
2020-06-09 - ?
Eligibility criteria
Suitability:

1. Участникът трябва да има право да осъществява търговия на едро с лекарствени продукти. За целта той следва да разполага с разрешение за търговия на едро с лекарства, или удостоверение за регистрация на търговия на едро, или разрешение за производство; или разрешение за внос, издадени на негово име по реда на ЗЛПХМ.Доказване: за доказване на съответствието с посочения критерий, при подаване на офертата участникът попълва съответните полета на част IV, раздел А. „Годност“, посочвайки органа, издал документа, обхват, дата на издаване, срок на валидност и посочване на националните бази данни, в които се съдържат декларираните обстоятелства, или компетентните органи съгласно законодателството на държавата, в която участникът е установен, са длъжни да предоставят информация. Преди сключването на договора за обществена поръчка, участникът определен за изпълнител, доказва изпълнението на поставеното изискване с представяне на съответното разрешение.2. Всеки участник за обособените позиции с предмет лекарствени продукти, съдържащи наркотични вещества (позиции № 32, 33, 38, 41, 51, 52, 53, 60, 74, 76), трябва да отговаря на изискванията за търговия с лекарствени продукти, съдържащи наркотични вещества.Доказване: за доказване на съответствието с посочения критерий при подаване на офертата участникът попълва съответните полета на част IV, раздел А. „Годност“, посочвайки органа, издал документа, обхват, дата на издаване, срок на валидност и посочване на националните бази данни, в които се съдържат декларираните обстоятелства, или компетентните органи съгласно законодателството на държавата, в която участникът е установен, са длъжни да предоставят информация. Преди сключването на договора за обществена поръчка участникът, определен за изпълнител, доказва изпълнението на поставеното изискване с представяне на съответното разрешение.

Economic/financial eligibility:

1. Участникът трябва да има оборот от продажба на лекарствени продукти. За доказване на съответствието с посочения критерий, при подаване на офертата участникът попълва съответните полета на част IV, Раздел Б. „Икономическо и финансово състояние“ от ЕЕДОП, посочвайки своя годишен оборот и своя конкретен оборот. Преди сключването на договора за обществена поръчка участникът, определен за изпълнител, доказва изпълнението на поставеното изискване с представяне на годишните си финансови отчети за последните 3 (три) години, освен ако същите не са обявени в Търговския регистър към Агенция по вписванията.

Economic/financial minimum level:

Участникът трябва да има минимален оборот от продажба на лекарствени продукти за последните 3 (три) години (2017, 2018 и 2019 г.), който трябва да бъде два пъти стойността на позицията/позициите, за която/които кандидатства.

Technical/professional eligibility:

1. Участникът трябва да е изпълнил договори с предмет, сходен на този на обществената поръчка, сключени с лечебни заведения на територията на Р. БЪЛГАРИЯ, или с еквивалентни лечебни заведения на територията на други държави. За доказване на съответствието с посочения критерий, при подаване на офертата участникът попълва съответното поле на част IV, раздел В. „Технически и професионални способности“ на ЕЕДОП. Поставеното изискване се доказва с документи по чл. 64, ал. 1, т. 2 от ЗОП — списък на доставките, които са идентични или сходни с предмета на обществената поръчка, с посочване на стойностите, датите и получателите, заедно с доказателство за извършените доставки. Преди сключването на договора за обществена поръчка, участникът определен за изпълнител, доказва изпълнението на поставеното изискване с представяне на референции, удостоверения или други еквивалентни документи.

Technical/professional minimum level:

През последните 3 години, считано от датата на подаване на офертата, участникът трябва да е изпълнил минимум 3 (три) договора с предмет, сходен на този на обществената поръчка, сключени с лечебни заведения на територията на Р. БЪЛГАРИЯ, или с еквивалентни лечебни заведения на територията на други държави.
Main procurement category
goods
Procurement method
open
Procurement method details
Open procedure
Tender period
2020-05-07 - 2020-06-09
Value
51 414 313.97 BGN
Minimum value
51 414 313.97 BGN

Tender item

ID
ocds-pyfy63:2020-211846:obj:1
Classification
CPV / 33600000
Description
L01XC07 Bevacizumab concentrate for solution for infusion - mg-500 000,00.

Tender item

ID
ocds-pyfy63:2020-211846:obj:2
Classification
CPV / 33600000
Description
L01XX44 Aflibercept concentrate for sol. for inf. mg 72 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:3
Classification
CPV / 33600000
Description
B03XA02 Darbepoetin alfa Solution for injection pre-filled syringe with needle guard mcg 126 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:4
Classification
CPV / 33600000
Description
L01AA06 Ifosfamide power for solution for injection mg 480 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:5
Classification
CPV / 33600000
Description
L01BA04 Pemetrexed powd. for conc. for infusion mg90 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:6
Classification
CPV / 33600000
Description
L01BC05 Gemcitabine concentrate for solution for infusion mg 1 600 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:7
Classification
CPV / 33600000
Description
L01BC06 Capecitabine film-coated tablets mg 21 600 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:8
Classification
CPV / 33600000
Description
L01CA04 Vinorelbine concentrate for solution for infusion mg 18 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:9
Classification
CPV / 33600000
Description
L01CB01 Etoposide concentrate for solutuion for infusion mg 140 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:10
Classification
CPV / 33600000
Description
L01CD01 Paclitaxel sol.for inf. mg 272 700,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:11
Classification
CPV / 33600000
Description
L01CD02 Docetaxel concentrate for solution for infusion mg 113 920,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:12
Classification
CPV / 33600000
Description
L01DB03 Epirubicin solution for infusion mg 60 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:13
Classification
CPV / 33600000
Description
L01XA01 Cisplatin concentrate for solution for infusion mg 45 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:14
Classification
CPV / 33600000
Description
L01XA02 Carboplatin solution for infusion mg 270 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:15
Classification
CPV / 33600000
Description
L01XA03 Oxaliplatin powder for solution for infusion mg 100 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:16
Classification
CPV / 33600000
Description
L01XC06 Cetuximab solution for infusion mg 200 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:17
Classification
CPV / 33600000
Description
L01XE03 Erlotinib film-coated tablets mg 803 400,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:18
Classification
CPV / 33600000
Description
L01XE04 Sunitinib hard capsules mg 135 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:19
Classification
CPV / 33600000
Description
L01XE05 Sorafenib film coated tablets mg 1 881 600,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:20
Classification
CPV / 33600000
Description
L01XE07 Lapatinib film-coated tablets, bottle mg 1 319 500,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:21
Classification
CPV / 33600000
Description
L01XE10 Everolimus tablets mg 72 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:22
Classification
CPV / 33600000
Description
L01XE11 Pazopanib film-coated tablets mg 2 589 600,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:23
Classification
CPV / 33600000
Description
L01XX17 Topotecan powder for concentrate for solution for infusion mg 500,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:24
Classification
CPV / 33600000
Description
L01XX19 Irinotecan concentrate for solution for infusion mg 172 500,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:25
Classification
CPV / 33600000
Description
L01XX41 Eribulin solution for infusion mg 308,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:26
Classification
CPV / 33600000
Description
L02BB04 Enzalutamide film-coated tablets mg 2 419 200,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:27
Classification
CPV / 33600000
Description
L02BX03 Abiraterone film-coated tablets mg 16 200 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:28
Classification
CPV / 33600000
Description
L03AA13 Pegfilgrastim pre - filled syr. mg 2 520,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:29
Classification
CPV / 33600000
Description
L03AX03 Mycobacterium bovis BCG powder for suspension mg 54 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:30
Classification
CPV / 33600000
Description
M05BX04 Denosumab solution for injection mg 252 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:31
Classification
CPV / 33600000
Description
M05BA08 Zoledronic acid solution for infusion mg 9 600,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:32
Classification
CPV / 33600000
Description
N02AA01 Morphine prolonged release tablets mg 976 950,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:33
Classification
CPV / 33600000
Description
N02AA08 Dihydrocodeine modified-release tablets mg 1 640 340,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:34
Classification
CPV / 33600000
Description
V03AF03 Calcium folinate concentrate for solution for infusion mg 1 132 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:35
Classification
CPV / 33600000
Description
L01XC21 Ramucirumab concentrate for solution for infusion mg 72 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:36
Classification
CPV / 33600000
Description
L01XE13 Afatinib film-coated tablets mg 58 800,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:37
Classification
CPV / 33600000
Description
L01XE23 Dabrafenib capsules mg 630 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:38
Classification
CPV / 33600000
Description
N02AB03 Fentanyl transdermal patches mcg/h 500 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:39
Classification
CPV / 33600000
Description
L03AA14 Lipegfilgrastim solution for injection in pre-filled syringe mg 420,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:40
Classification
CPV / 33600000
Description
L01XE01 Imatinib film-coated tablets mg 2 520 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:41
Classification
CPV / 33600000
Description
N02AE01 Buprenorphine transdermal patches mcg/h 294 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:42
Classification
CPV / 33600000
Description
L01XC14 Trastuzumab Emtansine powder for concentrate for solution for infusion mg 57 600,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:43
Classification
CPV / 33600000
Description
L01XX43 Vismodegib hard capsule mg 117 600,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:44
Classification
CPV / 33600000
Description
L01XE17 Axitinib film-coated tablets mg 19 600,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:45
Classification
CPV / 33600000
Description
L01XE16 Crizotinib hard capsules mg 630 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:46
Classification
CPV / 33600000
Description
L01XE12 Vandetanib tablets mg 630 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:47
Classification
CPV / 33600000
Description
B03XA01 Erythropoietin (Epoetin alfa) solution for injection in pre-filled syringe IU 54 002 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:48
Classification
CPV / 33600000
Description
H02AB02 Dexamethasone sol. inj. mg 128 372,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:49
Classification
CPV / 33600000
Description
L01AA01 Cyclophosphamide power for solution for injection mg 440 700,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:50
Classification
CPV / 33600000
Description
L03AA02 Filgrastim solution for injection in pre-filled syringe mcg 2 010 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:51
Classification
CPV / 33600000
Description
N02AA01 Morphine sol. inj. mg 240 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:52
Classification
CPV / 33600000
Description
N02AA05 Oxycodone prolonged release tablets mg 2 000 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:53
Classification
CPV / 33600000
Description
N02AX02 Tramadol capsules mg 4 000 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:54
Classification
CPV / 33600000
Description
L01XX46 Olaparib Film coated tablet mg 2 016 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:55
Classification
CPV / 33600000
Description
L01BC02 Fluorouracil concentrate for solution for infusion mg 7 488 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:56
Classification
CPV / 33600000
Description
L01CD04 Cabazitaxel concentrate for solution for infusion mg 12 600,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:57
Classification
CPV / 33600000
Description
V03AF01 Uromitexan solution for injection mg 960 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:58
Classification
CPV / 33600000
Description
L01XC03 Trastuzumab powder for concentrate for solution for infusion mg 87 750,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:59
Classification
CPV / 33600000
Description
L01XC03 Trastuzumab solution for injection mg 390 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:60
Classification
CPV / 33600000
Description
N02AA05 Oxycodone capsules, hard mg 900 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:61
Classification
CPV / 33600000
Description
L01DC03 Mitomycin powder for solution for injection/infusion or intravesical use mg 72 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:62
Classification
CPV / 33600000
Description
L01DB01 Doxorubicin Hydrochloride powder for concentrate for solution for infusion mg 8 400,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:63
Classification
CPV / 33600000
Description
L01XE02 Gefitinib film-coated tablets mg 420 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:64
Classification
CPV / 33600000
Description
L03AB04 Interferon alfa-2a solution for injection MU 2 520,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:65
Classification
CPV / 33600000
Description
L01DB07 Mitoxantrone concentrate for solution for infusion mg 1 400,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:66
Classification
CPV / 33600000
Description
H01CB02 Octreotide powder for infusion mg 4 800,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:67
Classification
CPV / 33600000
Description
L01XC08 Panitumumab concentrate for solution for infusion mg 28 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:68
Classification
CPV / 33600000
Description
L01BC53 Tegafur, Gimeracil, Oteracil capsules mg 235 494,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:69
Classification
CPV / 33600000
Description
L01AX03 Temozolomide capsules, hard mg 228 800,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:70
Classification
CPV / 33600000
Description
L01XE09 Temsirolimus concentrate and solvent for solution for injection mg 1 200,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:71
Classification
CPV / 33600000
Description
L01XE15 Vemurafenib film-coated tabl. mg 3 225 600,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:72
Classification
CPV / 33600000
Description
L01XC13 Pertuzumab concentrate for solution for infusion mg 90 700,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:73
Classification
CPV / 33600000
Description
L01XC18 Рembrolizumab concentrate for solution for infusion mg. 51 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:74
Classification
CPV / 33600000
Description
N02AA55 Oxycodone, Naloxone prolonged release tablets mg 900 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:75
Classification
CPV / 33600000
Description
L01BA04 Pemetrexed concentrate for solution for infusion mg 84 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:76
Classification
CPV / 33600000
Description
N02AB03 Fentanyl sublingual tablets mcg 159 600,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:77
Classification
CPV / 33600000
Description
L01XC32 Atezolizumab Concentrate for solution for infusion mg 204 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:78
Classification
CPV / 33600000
Description
L01XE36 Alectinib Capsule, hard mg 2 184 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:79
Classification
CPV / 33600000
Description
L01BC59 Trifluridine/Tipiracil Film coated tablet 20/ 8,19 mg 360 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:80
Classification
CPV / 33600000
Description
L01BC59 Trifluridine/Tipiracil Film coated tablet 15/ 6,14 mg 180 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:81
Classification
CPV / 33600000
Description
L01XC17 Nivolumab Concentrate for solution for infusion mg 57 600,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:82
Classification
CPV / 33600000
Description
L01XE35 Osimertinib Film coated tablet mg 80 640,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:83
Classification
CPV / 33600000
Description
L01XE42 Ribociclib Film coated tablet mg 4 536 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:84
Classification
CPV / 33600000
Description
L01XE33 palbociclib Capsule, hard mg 1 260 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:85
Classification
CPV / 33600000
Description
L01XE21 Regorafenib Film coated tablet 40 mg 403 200,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:86
Classification
CPV / 33600000
Description
L01XE25 Trametinib Film coated tablet 2 mg 3 600,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:87
Classification
CPV / 33600000
Description
L01XC28 Durvalumab concetrate for infuson 50 mg/ml- 10 ml mg 24 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:88
Classification
CPV / 33600000
Description
L01XC28 Durvalumab concetrate for infuson 50 mg/ml - 2.4 ml mg mg 8 640,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:89
Classification
CPV / 33600000
Description
L01XE31 Nintedanib Capsule, soft 100 mg 480 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:90
Classification
CPV / 33600000
Description
L01XE38 Cobimetinib Film coated tablet mg 75 600,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:91
Classification
CPV / 33600000
Description
L01XC11 Ipilimumab Concentrate for solution for infusion mg 102 000,00

Tender item

ID
ocds-pyfy63:2020-211846:obj:92
Classification
CPV / 33600000
Description
L01XC31 Avelumab Concentrate for solution for infusion mg 57 600,00

Parties

Roles
buyer
Organization name
Spetsializirana bolnitsa za aktivno lechenie na onkologichni zabolyavaniya „Prof. d-r Marin Mushmov“ EOOD
Street address
bul. „Andrey Saharov“ No. 22
Locality
Sofiya
Postal code
1784
Country
BG
Contact name
Snezhana Zlatanova Hristova
E-mail
sbaloz.sofia-grad@mail.bg
Phone
+359 29753950
Fax
+359 29753950
Website
Link

Organization data Organization in JSON